This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies Find out more here
davidcracc
Last seen: 4 hours ago
Member since Mar 7, 2025
hmason@delveinsight.com
The B7-H3 Market Opportunity: Target Pop...
The B7-H3 (also known as CD276) protein is an immune checkpoint regulator that has attracted significant attention in cancer immun...
Photodynamic Therapy in Oncology: Target...
Photodynamic therapy (PDT) has evolved into a promising treatment modality for various cancers. By using light-sensitive compounds...